NCT04488900View on ClinicalTrials.gov

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

July 2, 2023

Study Completion Date

July 2, 2023

Conditions
Healthy Subjects
Interventions
DRUG

CKD-508 Capsule

Investigational drug

DRUG

Placebo Capsule

Placebo

DRUG

CKD-508 Tablet

Investigational drug

DRUG

Placebo Tablet

Placebo

Trial Locations (1)

HA1 3UJ

Northwick Park Hospital, Harrow

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY